Akari Therapeutics Plc

AKTX

Akari Therapeutics Plc

AKTX

Insider Sentiment (TTM):

Last Purchase:2025-08-25Last Sale:-Shares Purchased (TTM):3,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:4,452,851Shares Outstanding:67,328,129Institutional Ownership Pct.:6.61%

Earnings Market Reaction:

Filing Date:2026-05-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Akari Therapeutics Plc (AKTX) — SEC Financial Statements & Analysis

Akari Therapeutics Plc (AKTX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Assets
Cash And Cash Equivalents At Carrying Value	3	0	-	3	3	0	2	4	1	4
Assets Current
Assets Current	4	5	3	3	3	3	3	5	3	4
Cash	3	5	2	-	3	3	2	-	-	-
Restricted Cash	0	0	0	0	0	0	-	-	-	0
Prepaid Expense Current	1	0	0	0	1	0	0	1	1	0
Other Assets Current	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	-	-	-	-	0
Goodwill	-	8	8	8	8	8	-	-	-	-
Other Intangible Assets Net	30	34	34	39	39	39	-	-	-	-
Assets	34	48	45	51	51	51	3	5	3	4
Liabilities And Stockhold…
Accounts Payable Current	9	9	11	12	13	12	5	5	3	2
Liabilities Current
Accrued Liabilities Current	3	2	2	2	3	3	3	2	2	2
Liabilities Current	13	12	16	17	21	20	9	9	6	5
Convertible Debt	1	1	1	1	1	1	-	-	-	-
Notes Payable Current	0	0	0	0	0	1	-	-	-	-
Other Liabilities Current	1	0	0	1	0	0	0	1	1	0
Derivative Liabilities Noncurrent	-	0	0	-	-	-	-	-	-	-
Other Liabilities Noncurrent	-	0	0	0	0	0	-	-	-	-
Deferred Income Tax Liabilities Net	6	7	7	8	8	8	-	-	-	-
Liabilities	20	20	23	25	29	28	-	-	-	5
Common Stock Value	-	-	7	7	6	5	2	2	2	1
Additional Paid In Capital	235	234	224	221	216	213	183	183	176	175
Stockholders Equity
Stockholders Equity	14	28	23	26	22	22	-7	-4	-4	-0
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-279	-265	-259	-253	-251	-247	-243	-241	-233	-227
Liabilities And Stockholders Equity	34	48	45	51	51	51	3	5	3	4
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	381	381	331	331	368	368	338	338	338	338
Common Stock Shares Issued	229	226	228	228	231	239	243	243	240	238
Shares Outstanding	229	226	228	228	231	239	243	243	240	238

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	258.29%	271.12%	-	-	-	-	-	-	-	-	-	-
2025	-8.74%	-13.33%	-25.19%	-16.68%	-6.82%	-23.70%	-34.81%	-44.23%	-54.81%	19.83%	277.48%	126.03%
2024	52.74%	96.58%	151.71%	-9.58%	-25.00%	-31.94%	-38.03%	-22.61%	-21.02%	5.09%	2.75%	-2.42%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Liquidity Ratios
Current Ratio	0.27	0.44	0.19	0.19	0.16	0.15	0.29	0.58	0.44	0.95
Quick Ratio	0.21	0.43	0.17	0.17	0.13	0.14	0.25	0.49	0.24	0.88
Working Capital	-9.83M	-6.89M	-12.62M	-13.84M	-17.56M	-16.96M	-6.69M	-3.70M	-3.55M	-243.00K
Leverage & Debt
Debt to Equity	1.36	0.69	1.00	0.99	1.34	1.27	-1.41	-2.37	-1.78	-20.02
Interest Coverage TTM	-30.90	-18.20	-55.22	-49.83	-64.14	-88.70	-136.38	-339.02	-3,470.21	-11.19
Debt Ratio	0.58	0.41	0.50	0.50	0.57	0.56	3.45	1.73	2.28	1.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.47	-0.26	-0.24	-0.19	-0.33	-0.41	-0.33	-0.29	-0.09	-0.82
Free Cash Flow Per Share TTM	-0.18	-0.16	-0.15	-0.14	-0.20	-0.26	-0.21	-0.29	-0.34	-0.15
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	56.43%	-12.60%	-1.54%	-23.85%	251.06%	-59.01%	-65.63%	-64.45%	-89.53%	-
EPS Growth (1Y)	43.81%	-37.98%	-26.49%	-31.64%	246.07%	-49.60%	-60.16%	-65.70%	-89.04%	-
Valuation Metrics
P/E TTM	-10.90	-44.99	-167.33	-240.14	-151.01	-117.80	-359.27	-378.85	-785.99	-151.83
P/B	21.27	27.48	116.33	115.05	124.51	104.88	-859.74	-1,648.13	-1,129.87	-32,008.68
Market Cap	305.80M	778.31M	2.64B	2.95B	2.71B	2.33B	5.76B	6.10B	4.01B	7.33B
Enterprise Value	303.70M	773.80M	2.64B	2.94B	2.71B	2.33B	5.75B	6.10B	4.01B	7.33B
Calculated Values
Free Cash Flow TTM	-10.91M	-10.57M	-9.65M	-9.02M	-10.66M	-12.55M	-10.43M	-16.42M	-18.30M	-8.95M
Net Debt	-2.10M	-4.51M	-1.68M	-1.89M	-1.71M	-1.30M	-2.25M	-4.18M	-1.31M	-3.85M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-25Purchase

Owner: Gaslightwala, Abizer

Title: CEO

Shares: 3,000

Price/Share: $0.90

Value: $2,700.00

Shares Owned: 298,574

Relationship: Director,Officer

Ownership: Direct

2025-06-24Purchase

Owner: Gaslightwala, Abizer

Title: President & CEO

Shares: 5,203

Price/Share: $1.16

Value: $6,035.48

Shares Owned: 277,574

Relationship: Director,Officer

Ownership: Direct

2025-06-20Purchase

Owner: Gaslightwala, Abizer

Title: President & CEO

Shares: 10,000

Price/Share: $1.20

Value: $12,000.00

Shares Owned: 271,428

Relationship: Director,Officer

Ownership: Direct

2025-06-17Purchase

Owner: Gaslightwala, Abizer

Title: President & CEO

Shares: 15,000

Price/Share: $1.20

Value: $18,000.00

Shares Owned: 261,428

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-25	Gaslightwala, Abizer	Director,Officer	CEO	Direct	Purchase	3,000	0.90	$2,700.00	298,574	4
2025-06-24	Gaslightwala, Abizer	Director,Officer	President & CEO	Direct	Purchase	5,203	1.16	$6,035.48	277,574	4
2025-06-20	Gaslightwala, Abizer	Director,Officer	President & CEO	Direct	Purchase	10,000	1.20	$12,000.00	271,428	4
2025-06-17	Gaslightwala, Abizer	Director,Officer	President & CEO	Direct	Purchase	15,000	1.20	$18,000.00	261,428	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

6.61%

Inst. Shares: 4,452,851

Shares Outstanding: 67,328,129

2025-09-30

7.03%

Inst. Shares: 4,590,056

Shares Outstanding: 65,326,237

2025-06-30

3.47%

Inst. Shares: 2,185,432

Shares Outstanding: 62,943,896

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	4,452,851	67,328,129	6.61%
2025-09-30	4,590,056	65,326,237	7.03%
2025-06-30	2,185,432	62,943,896	3.47%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Akari Therapeutics Plc (AKTX) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.